QT Imaging Holdings, Inc. is a medical device company focused on the research, development, and commercialization of innovative body imaging systems using low energy sound. The company’s core activity centers on the QT Breast Scanner, a stationary mechanical device that uses ultra-low frequency transmitted sound and a novel sound back-scatter design with inverse-scattering reconstruction to create high-resolution three-dimensional images of breast tissue without ionizing radiation or compression. The technology is designed to improve global health outcomes by providing safe, affordable, and accessible imaging solutions, with applications extending to orthopedic, infant, and image-guided procedures through its Open Partial Angle Scanner platform. The company is headquartered in Novato, California.

QT Imaging Holdings, Inc. generates revenue primarily through the sale and servicing of its QT Breast Scanner systems and associated software, including the QTviewer® for image visualization and analysis. Revenue is derived from direct sales to healthcare providers, leasing arrangements, and ongoing technical support and maintenance contracts. The company also pursues revenue from strategic partnerships, such as distribution agreements with NXC for U. S. territories and GMC for Saudi Arabia, and manufacturing collaborations like the Canon Medical Agreement with CMSC for scaled production. Additionally, the company anticipates future revenue from its Cloud SaaS platform, which will deliver artificial intelligence and machine learning algorithms for quantitative feature extraction and diagnostic decision support across connected devices.

The company operates through the following segments: QT Breast Scanner, QT Orthopedic Scanner, QT Infant Scanner, and QT Cloud SaaS Platform.

• The QT Breast Scanner segment involves the commercialization of a FDA-cleared Class II medical device that provides reflection-mode and transmission-mode ultrasound images of the breast for adjunctive use with mammography, breast density measurement, mass size and growth tracking, and AI-based lesion diagnostics, with applications in screening high-risk younger women and monitoring cancer treatment.

• The QT Orthopedic Scanner segment focuses on developing a system for extremity imaging using transmission and reflection ultrasound to generate true 3D renderings of musculoskeletal structures such as knees, shoulders, and hips, offering a radiation-free, portable, and lower-cost alternative to MRI and CT for in-office diagnosis and treatment planning.

• The QT Infant Scanner segment is dedicated to creating a whole-body imaging solution for neonates and pediatric patients using the Open Partial Angle Scanner concept, designed to avoid ionizing radiation and anesthesia while enabling parental presence during scans to improve imaging efficacy and safety in vulnerable populations.

• The QT Cloud SaaS Platform segment encompasses the development of a biomarker-driven, DICOM-compatible cloud infrastructure to deliver real-time artificial intelligence and machine learning modules for automated lesion segmentation, volumetric tissue characterization, and computer-aided diagnosis, enabling secure, scalable updates to QT Breast Scanners without on-premise hardware changes.

QT Imaging Holdings, Inc. operates in the competitive medical imaging industry, particularly within the non-ionizing breast imaging segment, where it differentiates itself through its unique transmission ultrasound technology that provides true 3D imaging and functional data such as speed of sound measurements. The company competes with established players like Siemens (Acuson S2000 ABVS), GE Healthcare (Invenia System), Sono-Cine (manual AWBS), and Hitachi (Sofia System) in the Automated Breast Ultrasound Systems market, as well as Delphinus Medical Technologies in breast ultrasound tomography. Its competitive advantages include a lower price point, portability, lack of ionizing radiation or contrast agents, superior specificity in dense breast tissue, and a disruptive one-of-a-kind design that reduces bill-of-materials costs and total cost of ownership, enabling broader deployment in low-resource and point-of-care settings.

QT Imaging Holdings, Inc. serves healthcare providers including hospitals, radiology centers, imaging facilities, and point-of-care settings such as clinics and physician offices. The company also targets direct-to-consumer and direct-to-patient markets for personal medical imaging applications. Specific distribution partners include NXC for the United States and its territories, and GMC for Saudi Arabia, with prior engagements through Innovador for Asian markets. The company’s technology is intended for use by patients seeking alternatives to mammography and MRI, particularly women with dense breasts, breast implants, or those undergoing cancer treatment, as well as medical professionals requiring quantitative imaging for treatment monitoring and diagnostic precision.